THG · Insider Trading
The Hanover Insurance Group, Inc.
Every open-market purchase and sale reported by THG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-28 | Joseph R Ramrath | Director | A | +3 | — |
| 2026-09-28 | Kevin Bradicich | Director | A | +3 | — |
| 2026-09-28 | Jane D Carlin | Director | A | +3 | — |
| 2026-09-28 | J Paul Condrin | Director | A | +3 | — |
| 2026-09-28 | David John Lovely | Executive Vice President | A | +10 | — |
| 2026-09-28 | Jeffrey M Farber | Executive Vice President | A | +41 | — |
| 2026-09-28 | Patricia A. Norton-Gatto | SVP & Princpl. Accntg. Officer | A | +5 | — |
| 2026-09-28 | Elizabeth A Ward | Director | A | +3 | — |
| 2026-09-28 | John C Roche | President and CEO | A | +120 | — |
| 2026-09-28 | Kathy S Lane | Director | A | +3 | — |
| 2026-09-28 | Richard W Lavey | Executive Vice President | A | +27 | — |
| 2026-09-28 | Francisco Aristeguieta | Director | A | +3 | — |
| 2026-09-28 | Theodore H Bunting JR | Director | A | +3 | — |
| 2026-09-28 | Dennis Francis Kerrigan | Executive Vice President | A | +14 | — |
| 2026-09-28 | Cynthia Egan | Director | A | +3 | — |
| 2026-09-28 | Willard T Lee | Executive Vice President | A | +10 | — |
| 2026-09-28 | William E. Donnell | Director | A | +3 | — |
| 2026-09-28 | Bryan J Salvatore | Executive Vice President | A | +24 | — |
| 2026-08-21 | Dennis Francis Kerrigan | Executive Vice President | MIXED | — | −$888.40K |
| 2026-08-07 | Theodore H Bunting JR | Director | Sell | −1,200 | −$274.94K |
| 2026-08-07 | Theodore H Bunting JR | Director | Sell | −1,200 | −$274.94K |
| 2026-08-04 | Jane D Carlin | Director | Sell | −1,000 | −$231.50K |
| 2026-07-31 | Jeffrey M Farber | Executive Vice President | MIXED | +16,965 | −$3.69M |
| 2026-06-04 | Bryan J Salvatore | Executive Vice President | MIXED | — | −$1.34M |
| 2026-05-26 | Francisco Aristeguieta | Director | Sell | −1,000 | −$195.37K |
| 2026-05-21 | Dennis Francis Kerrigan | Executive Vice President | MIXED | — | −$486.18K |
| 2026-05-21 | John C Roche | President and CEO | MIXED | — | −$3.14M |
| 2026-05-19 | John C Roche | President and CEO | MIXED | — | −$2.00M |
| 2026-05-15 | Denise Lowsley | Executive Vice President | MIXED | — | −$318.89K |
| 2026-05-13 | Cynthia Egan | Director | A | +843 | — |
| 2026-05-13 | Jane D Carlin | Director | A | +843 | — |
| 2026-05-13 | Francisco Aristeguieta | Director | A | +843 | — |
| 2026-05-13 | Kevin Bradicich | Director | A | +843 | — |
| 2026-05-13 | Theodore H Bunting JR | Director | A | +843 | — |
| 2026-05-13 | J Paul Condrin | Director | A | +843 | — |
| 2026-05-13 | Joseph R Ramrath | Director | A | +843 | — |
| 2026-05-13 | Kathy S Lane | Director | A | +843 | — |
| 2026-05-13 | Elizabeth A Ward | Director | A | +843 | — |
| 2026-05-13 | William E. Donnell | Director | A | +843 | — |
| 2026-05-11 | Denise Lowsley | Executive Vice President | Sell | −1,062 | −$200.11K |
| 2026-05-05 | Willard T Lee | Executive Vice President | Sell | −1,000 | −$183.93K |
| 2026-05-04 | Cynthia Egan | Director | Sell | −3,400 | −$640.90K |
| 2026-03-31 | Bryan J Salvatore | Executive Vice President | A | +30 | — |
| 2026-03-31 | John C Roche | President and CEO | A | +152 | — |
| 2026-03-31 | Richard W Lavey | Executive Vice President | A | +35 | — |
| 2026-03-31 | Dennis Francis Kerrigan | Executive Vice President | A | +18 | — |
| 2026-03-31 | Jeffrey M Farber | Executive Vice President | A | +53 | — |
| 2026-03-31 | Denise Lowsley | Executive Vice President | A | +12 | — |
| 2026-03-31 | David John Lovely | Executive Vice President | A | +13 | — |
| 2026-03-31 | Willard T Lee | Executive Vice President | A | +13 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| John C Roche | President and CEO | 155,707 | $36.28M |
| Jeffrey M Farber | Executive Vice President | 68,819 | $16.03M |
| Richard W Lavey | Executive Vice President | 34,474 | $8.03M |
| Joseph R Ramrath | Director | 33,837 | $7.88M |
| Bryan J Salvatore | Executive Vice President | 29,117 | $6.78M |
| Dennis Francis Kerrigan | Executive Vice President | 12,017 | $2.80M |
| Cynthia Egan | Director | 11,186 | $2.61M |
| Kevin Bradicich | Director | 10,099 | $2.35M |
| Kathy S Lane | Director | 7,605 | $1.77M |
| J Paul Condrin | Director | 6,359 | $1.48M |
| Willard T Lee | Executive Vice President | 6,003 | $1.40M |
| Elizabeth A Ward | Director | 5,886 | $1.37M |
| Theodore H Bunting JR | Director | 5,838 | $1.36M |
| Jane D Carlin | Director | 4,579 | $1.07M |
| Francisco Aristeguieta | Director | 4,060 | $945.97K |
| Denise Lowsley | Executive Vice President | 3,882 | $904.51K |
| David John Lovely | Executive Vice President | 3,828 | $892.03K |
| Warren E. Barnes | SVP & Princpl. Accntg. Officer | 3,264 | $760.65K |
| Patricia A. Norton-Gatto | SVP & Princpl. Accntg. Officer | 2,451 | $571.18K |
| William E. Donnell | Director | 1,827 | $425.74K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the THG quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.